Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6243]

Targeting B-cells may boost immunotherapy in liver cancer treatment

Targeting B-cells may boost immunotherapy in liver cancer treatment

World-first discovery uncovers how glioblastoma tumours dodge chemotherapy, potentially opening the door to new treatments

World-first discovery uncovers how glioblastoma tumours dodge chemotherapy, potentially opening the door to new...

Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching

Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity...

Dual-function biomaterials for postoperative osteosarcoma: Tumour suppression and bone regeneration

Dual-function biomaterials for postoperative osteosarcoma: Tumour suppression and bone regeneration

Scientists use ultrasound to soften and treat cancer tumors without damaging healthy tissue

Scientists use ultrasound to soften and treat cancer tumors without damaging healthy tissue

This new understanding of T cell receptors may improve cancer immunotherapies

This new understanding of T cell receptors may improve cancer immunotherapies

A new immunotherapy approach could work for many types of cancer

A new immunotherapy approach could work for many types of cancer

Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics

Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics

Proton therapy shows survival benefit in phase III trial for patients with head and neck cancers

Proton therapy shows survival benefit in phase III trial for patients with head and neck cancers

Personalised cancer medicine: New insights into the benefits and risks of therapies

Personalised cancer medicine: New insights into the benefits and risks of therapies

More from ecancer